Christopher McKinney

Mr. McKinney joined Kohlberg in 2018 and was named a Managing Director in 2024. Prior to joining the Firm, Mr. McKinney was in the Industrials Group at Bank of America Merrill Lynch. He is a member of the board of directors of Cadence, PCI Pharma Services, Trinity Life Sciences and Worldwide Clinical Trials. Mr. McKinney received a B.S. from Boston College.